Search research articles
Contact Us
Filters
Showing results (921-930 of 1,003) with videos related to
Page
of 101
Sort By:
Molecular Pharmaceutics
|
April 11, 2024
Physiologically Based Biopharmaceutics Modeling (PBBM): Best Practices for Drug Product Quality, Regulatory and Industry Perspectives: 2023 Workshop Summary Report
Claire Mackie, Sumit Arora, Paul Seo, et al.
The Journal of Organic Chemistry
|
March 23, 2022
Stereoselective Synthesis of the IDO Inhibitor Navoximod
Frédéric St-Jean, Rémy Angelaud, Stephan Bachmann, et al.
American Journal of Surgery
|
March 23, 2019
Assessing quality and resources during campus-wide simulation integration
Joshua J Weis, Deborah C Hogg, Melanie Sulistio, et al.
Ophthalmology Science
|
April 24, 2026
Retinal Blood Flow Decreases After Treatment with Laser Photocoagulation for Retinopathy of Prematurity
Shaiza Mansoor, Christina Kilby, Joyce Wang, et al.
MMWR. Morbidity and Mortality Weekly Report
|
June 20, 2020
Outbreak of Severe Hypoglycemia After Ingestion of a Male Enhancement Supplement - Virginia, August-November 2019
Jennifer A Ross, John W Downs, Lindsay A Bazydlo, et al.
Communications Biology
|
March 19, 2023
CCR3 plays a role in murine age-related cognitive changes and T-cell infiltration into the brain
Sanket V Rege, Arnaud Teichert, Juliet Masumi, et al.
Plos One
|
January 6, 2018
Cost and affordability of non-communicable disease screening, diagnosis and treatment in Kenya: Patient payments in the private and public sectors
Sujha Subramanian, Robai Gakunga, Joseph Kibachio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 4, 2009
Treatment of Philadelphia-positive chronic myeloid leukemia with imatinib: importance of a stable molecular response
Francesca Palandri, Ilaria Iacobucci, Simona Soverini, et al.
Blood
|
February 13, 2009
Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party
Fausto Castagnetti, Francesca Palandri, Marilina Amabile, et al.
Haematologica
|
March 23, 2010
The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase
Francesca Palandri, Fausto Castagnetti, Ilaria Iacobucci, et al.
Page
of 101
Search research articles
Search
Showing results (921-930 of 1,003) with videos related to
Sort By:
Page
of 101
Molecular Pharmaceutics
|
April 11, 2024
Physiologically Based Biopharmaceutics Modeling (PBBM): Best Practices for Drug Product Quality, Regulatory and Industry Perspectives: 2023 Workshop Summary Report
Claire Mackie, Sumit Arora, Paul Seo, et al.
The Journal of Organic Chemistry
|
March 23, 2022
Stereoselective Synthesis of the IDO Inhibitor Navoximod
Frédéric St-Jean, Rémy Angelaud, Stephan Bachmann, et al.
American Journal of Surgery
|
March 23, 2019
Assessing quality and resources during campus-wide simulation integration
Joshua J Weis, Deborah C Hogg, Melanie Sulistio, et al.
Ophthalmology Science
|
April 24, 2026
Retinal Blood Flow Decreases After Treatment with Laser Photocoagulation for Retinopathy of Prematurity
Shaiza Mansoor, Christina Kilby, Joyce Wang, et al.
MMWR. Morbidity and Mortality Weekly Report
|
June 20, 2020
Outbreak of Severe Hypoglycemia After Ingestion of a Male Enhancement Supplement - Virginia, August-November 2019
Jennifer A Ross, John W Downs, Lindsay A Bazydlo, et al.
Communications Biology
|
March 19, 2023
CCR3 plays a role in murine age-related cognitive changes and T-cell infiltration into the brain
Sanket V Rege, Arnaud Teichert, Juliet Masumi, et al.
Plos One
|
January 6, 2018
Cost and affordability of non-communicable disease screening, diagnosis and treatment in Kenya: Patient payments in the private and public sectors
Sujha Subramanian, Robai Gakunga, Joseph Kibachio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 4, 2009
Treatment of Philadelphia-positive chronic myeloid leukemia with imatinib: importance of a stable molecular response
Francesca Palandri, Ilaria Iacobucci, Simona Soverini, et al.
Blood
|
February 13, 2009
Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party
Fausto Castagnetti, Francesca Palandri, Marilina Amabile, et al.
Haematologica
|
March 23, 2010
The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase
Francesca Palandri, Fausto Castagnetti, Ilaria Iacobucci, et al.
Page
of 101